Targeting base excision repair as a sensitization strategy in radiotherapy

Seminars in Radiation Oncology

Volumn 20, Issue 4, 2010, Pages 241-249

  Vens, Conchita ^a   Begg, Adrian C ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; FEN1 ENZYME; FLAP ENDONUCLEASE; NUCLEAR PROTEIN; PROTEIN APE1; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; CYTOTOXICITY; DNA REPAIR; DOWN REGULATION; EXCISION REPAIR; HUMAN; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RADIATION INJURY REPAIR; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TREATMENT RESPONSE; UPREGULATION;

DNA BREAKS, DOUBLE-STRANDED; DNA BREAKS, SINGLE-STRANDED; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; RADIATION ONCOLOGY; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 77956490653     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.05.005     Document Type: Review

References (70)

1. Hegde M.L., Hazra T.K., Mitra S. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res 2008, 18:27-47.
2. Almeida K.H., Sobol R.W. A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 2007, 6:695-711.
3. Caldecott K.W. Single-strand break repair and genetic disease. Nat Rev Genet 2008, 9:619-631.
4. An Q., Robins P., Lindahl T., et al. C -> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. EMBO J 2005, 24:2205-2213.
5. Aller P., Rould M.A., Hogg M., et al. A structural rationale for stalling of a replicative DNA polymerase at the most common oxidative thymine lesion, thymine glycol. Proc Natl Acad Sci U S A 2007, 104:814-818.
6. Sobol R.W., Horton J.K., Kuhn R., et al. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 1996, 379:183-186.
7. Vermeulen C., Verwijs-Janssen M., Cramers P., et al. Role for DNA polymerase beta in response to ionizing radiation. DNA Repair (Amst) 2007, 6:202-212.
8. Vermeulen C., Verwijs-Janssen M., Begg A.C., et al. Cell cycle phase dependent role of DNA polymerase beta in DNA repair and survival after ionizing radiation. Radiother Oncol 2008, 86:391-398.
9. Breslin C., Caldecott K.W. DNA 3'-phosphatase activity is critical for rapid global rates of single-strand break repair following oxidative stress. Mol Cell Biol 2009, 29:4653-4662.
10. Shinmura K., Tao H., Goto M., et al. Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer. Carcinogenesis 2004, 25:2311-2317.
11. Rosenquist T.A., Zaika E., Fernandes A.S., et al. The novel DNA glycosylase, NEIL1, protects mammalian cells from radiation-mediated cell death. DNA Repair (Amst) 2003, 2:581-591.
12. Audebert M., Chevillard S., Levalois C., et al. Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res 2000, 60:4740-4744.
13. Bristow R.G. Oxygen, DNA repair and genetic instability: Implications for radiation oncology. Radiol Oncol 2010, 90. S22-S22.
14. Sak S.C., Harnden P., Johnston C.F., et al. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res 2005, 11:6205-6211.
15. Fan R., Kumaravel T.S., Jalali F., et al. Defective DNA strand break repair after DNA damage in prostate cancer cells: Implications for genetic instability and prostate cancer progression. Cancer Res 2004, 64:8526-8533.
16. Bobola M.S., Blank A., Berger M.S., et al. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas. Clin Cancer Res 2001, 7:3510-3518.
17. Bobola M.S., Finn L.S., Ellenbogen R.G., et al. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 2005, 11:7405-7414.
18. Kelley M.R., Cheng L., Foster R., et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref 1 in prostate cancer. Clin Cancer Res 2001, 7:824-830.
19. Zheng L., Dai H., Zhou M., et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat Med 2007, 13:812-819.
20. Starcevic D., Dalal S., Sweasy J.B. Is there a link between DNA polymerase beta and cancer?. Cell Cycle 2004, 3:998-1001.
21. Lang T., Dalal S., Chikova A., et al. The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol Cell Biol 2007, 27:5587-5596.
22. Lang T., Maitra M., Starcevic D., et al. A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc Natl Acad Sci U S A 2004, 101:6074-6079.
23. Sweasy J.B., Lang T., Starcevic D., et al. Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. Proc Natl Acad Sci U S A 2005, 102:14350-14355.
24. Albertella M.R., Lau A., O'Connor M.J. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst) 2005, 4:583-593.
25. Yoshizawa K., Jelezcova E., Brown A.R., et al. Gastrointestinal hyperplasia with altered expression of DNA polymerase beta. PLoS ONE 2009, 5. e6493-e2009.
26. Trivedi R.N., Wang X.H., Jelezcova E., et al. Human methyl purin DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol Pharmacol 2008, 74:505-516.
27. Robertson K.A., Bullock H.A., Xu Y., et al. Altered expression of Ape1/ref 1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001, 61:2220-2225.
28. Herring C.J., West C.M., Wilks D.P., et al. Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, ref 1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer 1998, 78:1128-1133.
29. Jenner T.J., Fulford J., O'Neill P. Contribution of base lesions to radiation-induced clustered DNA damage: Implication for models of radiation response. Radiat Res 2001, 156:590-593.
30. Kozmin S.G., Sedletska Y., Reynaud-Angelin A., et al. The formation of double-strand breaks at multiply damaged sites is driven by the kinetics of excision/incision at base damage in eukaryotic cells. Nucleic Acids Res 2009, 37:1767-1777.
31. Weinfeld M., Rasouli-Nia A., Chaudhry M.A., et al. Response of base excision repair enzymes to complex DNA lesions. Radiat Res 2001, 156:584-589.
32. Yang N., Galick H., Wallace S.S. Attempted base excision repair of ionizing radiation damage in human lymphoblastoid cells produces lethal and mutagenic double strand breaks. DNA Repair (Amst) 2004, 3:1323-1334.
33. Clairmont C.A., Sweasy J.B. Dominant negative rat DNA polymerase beta mutants interfere with base excision repair in Saccharomyces cerevisiae. J Bacteriol 1996, 178:656-661.
34. Vens C., Dahmen-Mooren E., Verwijs-Janssen M., et al. The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cells. Nucleic Acids Res 2002, 30:2995-3004.
35. Vens C., Hofland I., Begg A.C. Involvement of DNA polymerase beta in repair of ionizing radiation damage as measured by in vitro plasmid assays. Radiat Res 2007, 168:281-291.
36. Neijenhuis S., Verwijs-Janssen M., Kasten-Pisula U., et al. Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta. DNA Repair (Amst) 2009, 8:336-346.
37. Raaphorst G.P., Cybulski S.E., Sobol R., et al. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation. Anticancer Res 2001, 21:2079-2083.
38. Makridakis N.M., Caldas Ferraz L.F., Reichardt J.K. Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif. Hum Mutat 2009, 30:39-48.
39. Ide H., Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 2004, 27:480-485.
40. Bernstein N.K., Karimi-Busheri F., Rasouli-Nia A., et al. Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors. Anti Cancer Agents Med Chem 2008, 8:358-367.
41. Freschauf G.K., Karimi-Busheri F., Ulaczyk-Lesanko A., et al. Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase/phosphatase. Cancer Res 2009, 69:7739-7746.
42. Fishel M.L., Kelley M.R. The DNA base excision repair protein Ape1/ref 1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007, 28:375-395.
43. Batuello C.N., Kelley M.R., Dynlacht J.R. Role of Ape1 and base excision repair in the radioresponse and heat-radiosensitization of HeLa cells. Anticancer Res 2009, 29:1319-1325.
44. Xiang D.B., Chen Z.T., Wang D., et al. Chimeric adenoviral vector ad 5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther 2008, 15:625-635.
45. Simeonov A., Kulkarni A., Dorjsuren D., et al. Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1. PLoS ONE 2009, 4. e5740-e2009.
46. Mizushina Y., Kasai N., Miura K., et al. Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta. Biochemistry 2004, 43:10669-10677.
47. Hazan C., Boudsocq F., Gervais V., et al. Structural insights on the pamoic acid and the 8-kDa domain of DNA polymerase beta complex: Towards the design of higher-affinity inhibitors. BMC Struct Biol 2008, 8:22.
48. Yang J., Parsons J., Nicolay N.H., et al. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene 2009, 29:463-468.
49. Neijenhuis S., Begg A.C., Vens C. Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent. Radiother Oncol 2005, 76:123-128.
50. Mitchell J.B., Russo A., Cook J.A., et al. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers. Int J Radiat Biol 1989, 56:827-836.
51. Schulz C.A., Mehta M.P., Badie B., et al. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: A phase I clinical study. Int J Radiat Oncol Biol Phys 2004, 59:1107-1115.
52. Berry S.E., Kinsella T.J. Targeting DNA mismatch repair for radiosensitization. Semin Radiat Oncol 2001, 11:300-315.
53. Taverna P., Liu L., Hwang H.S., et al. Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. Mutat Res 2001, 485:269-281.
54. Yan T., Seo Y., Schupp J.E., et al. Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence. Mol Cancer Ther 2006, 5:893-902.
55. Golding S.E., Rosenberg E., Neill S., et al. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 2007, 67:1046-1053.
56. Wang H., Wang X., Iliakis G., et al. Caffeine could not efficiently sensitize homologous recombination repair-deficient cells to ionizing radiation-induced killing. Radiat Res 2003, 159:420-425.
57. Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy. Cancer Sci 2008, 99:187-194.
58. Tanner B., Grimme S., Schiffer I., et al. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecol Oncol 2004, 92:568-577.
59. Zhang Y., Wang J., Xiang D., et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-one/redox factor 1 (APE1/ref 1) in human ovarian cancer and identification of the therapeutic potential of APE1/ref 1 inhibitor. Int J Oncol 2009, 35:1069-1079.
60. Yang N., Chaudhry M.A., Wallace S.S. Base excision repair by hNTH1 and hOGG1: A two edged sword in the processing of DNA damage in gamma-irradiated human cells. DNA Repair (Amst) 2006, 5:43-51.
61. Kohno T., Shinmura K., Tosaka M., et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
62. Srivastava D.K., Husain I., Arteaga C.L., et al. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis 1999, 20:1049-1054.
63. Miura M., Watanabe H., Okochi K., et al. Biological response to ionizing radiation in mouse embryo fibroblasts with a targeted disruption of the DNA polymerase beta gene. Radiat Res 2000, 153:773-780.
64. Dobashi Y., Shuin T., Tsuruga H., et al. DNA polymerase beta gene mutation in human prostate cancer. Cancer Res 1994, 54:2827-2829.
65. Dong Z., Zhao G., Zhao Q., et al. [A study of DNA polymerase beta mutation in human esophageal cancer]. Zhonghua Yi Xue Za Zhi 2002, 82:899-902.
66. Dong Z.M., Zheng N.G., Wu J.L., et al. Difference in expression level and localization of DNA polymerase beta among human esophageal cancer focus, adjacent and corresponding normal tissues. Dis Esophagus 2006, 19:172-176.
67. Tan X.H., Zhao M., Pan K.F., et al. Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach. Cancer Lett 2005, 220:101-114.
68. Zhao G.Q., Wang T., Zhao Q., et al. Mutation of DNA polymerase beta in esophageal carcinoma of different regions. World J Gastroenterol 2005, 11:4618-4622.
69. Thompson T.E., Rogan P.K., Risinger J.I., et al. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. Cancer Res 2002, 62:3251-3256.
70. vanAnkeren S.C., Murray D., Stafford P.M., et al. Cell survival and recovery processes in Chinese hamster AA8 cells and in two radiosensitive clones. Radiat Res 1988, 115:223-237.